Re: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Dear Editor:
HCQ has no killing effect on the virus unless a Zinc supplement is used. In addition, the Z-Pak was not given. HCQ requires the zinc supplement and the Z-Pak and Dr Raoult in France has used it in past Corona virus cases with excellent positive response. Therefore it isn't surprising that no effect was seen. This is a major flaw in the study design. HCQ opens a door into the cell for the zinc which shuts down viral RNA Replicase. https://www.medcram.com/ has a large series of segments on COVID-19 on its you tube channel.
Fresh Air and Sunlight were effective in the treatment of the Post-War Flu Pandemic a hundred years ago and for the treatment of TB prior to the discovery of INH.
The most effective treatment for COVID-19 is two doses of Ivermectin a week apart along with Doxycycline 200mg once then 100mg QD x 4 and again after the next dose of Ivermectin.
Rapid Response:
Re: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Dear Editor:
HCQ has no killing effect on the virus unless a Zinc supplement is used. In addition, the Z-Pak was not given. HCQ requires the zinc supplement and the Z-Pak and Dr Raoult in France has used it in past Corona virus cases with excellent positive response. Therefore it isn't surprising that no effect was seen. This is a major flaw in the study design. HCQ opens a door into the cell for the zinc which shuts down viral RNA Replicase. https://www.medcram.com/ has a large series of segments on COVID-19 on its you tube channel.
Fresh Air and Sunlight were effective in the treatment of the Post-War Flu Pandemic a hundred years ago and for the treatment of TB prior to the discovery of INH.
The most effective treatment for COVID-19 is two doses of Ivermectin a week apart along with Doxycycline 200mg once then 100mg QD x 4 and again after the next dose of Ivermectin.
Competing interests: No competing interests